Acute upper gastrointestinal bleeding (AUGIB) remains a common emergency and potentially fatal situation that requires hospitalization. The incidence of AUGIB varies between 50-150 hospital admissions per 100,000 population in a year\[[@CIT1]--[@CIT5]\] (approximately 1% of all emergency room admissions).

Approximately 45--60% of admissions for AUGIB worldwide are due to peptic ulcers followed by esophagitis and esophageal varices.\[[@CIT2][@CIT6]\] Although, *H. pylori* infection has been one of the most common causes of peptic ulcer disease, and eventually AUGIB, in the developing countries in the last few years, it seems that due to better sanitation, better diagnostic and therapeutic approaches, rate of AUGIB secondary to *H. pylori* infection has been decreased.\[[@CIT4][@CIT7][@CIT8]\] On the other hand, excessive usage of low dose aspirin for primary or secondary prevention of atherosclerotic heart and brain diseases, increasing life expectancy and so increasing rate of degenerative joint disease and osteoarthropathies and excessive ingestion of other nonsteroidal antiinflammatory drugs (NSAIDS), may change the incidence, age of presentation, site of bleeding and outcome of patients with nonvariceal AUGIB in the last decade.\[[@CIT7][@CIT8]\]

It seems that better sanitation, vaccination against Hepatitis B virus, prophylactic using of propranolol, esophageal band ligation and liver transplantation has changed the incidence of esophageal variceal bleeding.\[[@CIT9]\]

Common use of high dose proton pump inhibitors, better availability of diagnostic and therapeutic endoscopy and increasing cost of hospitalization may change the economic burden of AUGIB.\[[@CIT10]\]

Despite the fact that epidemiologic data are important to get insight into the actual situation,\[[@CIT11]\] there is no epidemiologic survey regarding AUGIB in our area.

The aim of this study was to survey the etiology and clinical outcome of AUGIB in referred and already hospitalized patients of two hospitals in Shiraz.

MATERIALS AND METHODS {#sec1-1}
=====================

We prospectively evaluated clinical characteristics, cause of bleeding and clinical outcome, of 383 referred (*de novo*) and 189 already admitted (inpatients) referred to the Faghihi Hospital and Namazi Hospital.

Patients {#sec2-1}
--------

*De novo* patients: All adult patients (≥16 years old) who were admitted in emergency room with impression of AUGIB by internal medicine residents for more than 8 hours, were included in the study. All patients were admitted with a history of malaena or hematemesis on the day of admission

Ongoing hematemesis/melena {#sec2-2}
--------------------------

This was defined as a history of melena/hematemesis several days before admission and decrease in the hemoglobin level (\>1gm/dl), shock (blood pressure \<90/60 mmHg in supine position), pallor, orthostatic hypotension (\>20 mmHg decrease in systolic blood pressure or \>10mmHg in diastolic blood pressure from supine to standing position), or anemia (hemoglobin \< 12 gm/dl and \<14 gm/dl in female and male respectively), insertion of naso-gastric tube and suction of fresh blood or coffee-ground materials without clearance of gastric washing by 250 cc of isotonic solution and exclusion of other causes of false AUGIB, such as bleeding from upper respiratory tract, nose bleeding, bleeding from paranasal sinuses, etc.

In-hospital patients: AUGIB in hospital adult (≥16 years old) patients were confirmed with nonclearance of gastric washing by 250 cc of isotonic solution, positive stool occult blood test and no evidence of active bleeding from upper respiratory tract.

After enrolment in the study, a questionnaire including demographic data, important points in the history, physical exam and laboratory tests such as history of acid peptic disease, presence of cirrhosis, cause of cirrhosis, NSAID use, regular ingestion of low dose aspirin, previous history of AUGIB and cause of it, co-morbidities, ongoing vital signs, pallor, organomegaly, ascites, ongoing and 6 hour after admission hemoglobin (Hgb), activated prothrombin time (PT), platelet (Plt), partial thromboplastin time (PTT) etc was filled by research assistants. Upper GI endoscopy was performed by our on-call fellow or attending physician within 24 hours of admission. There was a daily follow-up of patients after admission and up to 15 days after being discharged from hospital. End points including mortality, re-bleeding in hospital and within 15 days after discharge, blood transfusion and surgery were registered.

Statistical analysis {#sec2-3}
--------------------

Statistical package for social sciences (*SPSS, version* 15.0; Chicago, IL, USA) and Epi Info 2000 programs were used for data analysis. Student T-test was used for quantitative and Chi-square and Fisher exact tests were used for qualitative variables.

RESULTS {#sec1-2}
=======

Five hundred and seventy two patients (including 383 *de novo* and 189 in-hospital) entered the study, of which 377 (66%) were male. The mean age of our patients was 54.9 years (±SD: 18.7). Other demographic data are shown in [Table 1](#T0001){ref-type="table"}.

###### 

Comparison and common complaints of patients with upper gastrointestinal bleeding

                                                Whole No.: 572 (%)   *de novo* No.: 383 (%)   In-hospital No.: 189 (%)   *P* value (*de novo* vs. In-hospital)
  --------------------------------------------- -------------------- ------------------------ -------------------------- ---------------------------------------
  Sex                                                                                                                    
   Male                                         377 (66)             257 (67)                 120 (64)                   NS[\#](#T000F1){ref-type="table-fn"}
   Female                                       195 (34)             126 (33)                 69 (36)                    
  Mean age/yr (±SD)                             54.9(18.7)           55(18.8)                 54.8(18.7)                 NS
  History related to bleeding                                                                                            
   Melena                                       217(38)              147 (38)                 70 (37)                    NS
   Hematemesis or coffee-ground vomitus         390(68)              263 (69)                 127 (67)                   NS
   Fainting or dizziness                        77(14)               54(14)                   23(12)                     NS
   Hematochezia                                 22(4)                15(4)                    7(4)                       NS
  Previous history of                                                                                                    
   Duodenal ulcer                               24(4)                16(4)                    8(4)                       NS
   Gastric ulcer                                67(12)               49(13)                   18(10)                     NS
   Portal hypertension                          12(2)                6(2)                     6(3)                       NS
   Cirrhosis                                    38 (7)               29 (8)                   9(5)                       NS
   Gl bleeding                                  66 (12)              47 (12)                  19(10)                     NS
  Co-morbidities                                400 (70)             254 (66)                 146 (72)                   0.007
  Ischemic heart disease                        34(9)                20 (8)                   14(10)                     NS
  Renal failure                                 9(2)                 6(2)                     3(2)                       NS
  Cerebro-vascular accident                     37 (9)               28(11)                   9(6)                       NS
  Malignancies                                  37 (9)               23 (9)                   14(10)                     NS
  Hypertension                                  87 (22)              63 (25)                  24(16)                     0.05
  Trauma                                        22 (6)               9(4)                     13(9)                      0.02
  Others                                        174 (44)             105 (41)                 69 (47)                    NS
  History of drug consumption                                                                                            
   ASA                                          172 (30)             118(31)                  54 (29)                    NS
   Celecoxib                                    10(2)                6(2)                     4(2)                       NS
   Other NSAIDs                                 255 (45)             166 (44)                 89 (47)                    NS
   Steroids[\$](#T000F2){ref-type="table-fn"}   53 (9)               31 (8)                   22 (12)                    NS
   Warfarin                                     42(7)                29 (8)                   13(7)                      NS
  Alcohol consumption                           48 (8)               34(9)                    14(7)                      NS
  History of smoking or addiction                                                                                        
   Water-pipe                                   139 (24)             91(24)                   48 (25)                    NS
   Cigarette                                    199 (35)             137 (36)                 62 (33)                    NS
   Morphine derivatives                         35 (6)               26 (7)                   9(5)                       NS

NS means statistically not significant

45/53 of these patients consumed NSAIDs (16 of them, low dose aspirin and 25 others consumed other types of NSAIDs) concomitantly

The most common symptom on presentation was hematemesis or coffee-ground vomits (68%) followed by melena (38%) in our patients. Sixteen percent of our patients gave history of acid peptic disease and 75% of them consumed low dose aspirin or other NSAIDs (except for celecoxib) regularly. Other basic histories are shown in [Table 1](#T0001){ref-type="table"}. On admission, 42% of our patients had orthostatic hypotension, with a mean hemoglobin level of 10.9 gm/ dl \[[Table 2](#T0002){ref-type="table"}\].

###### 

Clinical features on admission and primary laboratory results of patients with *de novo* upper gastrointestinal bleeding

  Test                                                        Result No.: 383 (%)
  ----------------------------------------------------------- ---------------------
  Orthostatic hypotension[\#](#T000F3){ref-type="table-fn"}   155 (42)
  Shock[\$](#T000F4){ref-type="table-fn"}                     8 (2)
  Splenomegaly                                                28 (7)
  Mean hemoglobin/gm/dl (±SD)                                 10.9 (2.5)
  Abnormal prothrombin time                                   69 (18)
  Abnormal partial thromboplastin time                        67 (18)
  Mean platelet/mm^3^ (±SD)                                   215227 (103790)
  Mean creatinine/mg/dl (±SD)                                 1.8 (5.3)

Drop of 20 mmHg or 10 mmHg in systolic or diastolic blood pressure respectively after 3 minutes sitting

Blood pressure \< 90/60 mmHg

Gastric ulcer was the most common finding in upper endoscopy. One hundred and seventy three patients had gastric ulcer (124/383, 32% and 49/189, 26% of *de novo* and in-hospital patients, respectively). The most common site was lesser curvature (57/173, 33%) and only 87/173 (50%) of these ulcers fulfilled criteria of low risk ulcer for rebleeding. Duodenal ulcer was present in 93 patient (62/383, 16%, and 31/189, 16% of *de novo* and in-hospital patients, respectively). 55/93 (59%) of these ulcers fulfilled criteria of low risk ulcer for re-bleeding. Esophageal varices were found in 64 patients (47/383, 12% and 17/189, 9% of *de novo* and in-hospital patients respectively). Eight of these patients had gastric ulcer (four Clean-based, one with oozing of blood from ulcer bed, and three with visible vessel) and five of them had clean based duodenal ulcer. Less than 10% of our patients had gastritis or Mallory-Weiss' tears as the causes of AUGIB and 99/572 (17%) of our patients had normal upper endoscopy \[[Table 3](#T0003){ref-type="table"}\].

###### 

Result of primary endoscopy in *de novo* and in-hospital patients with upper gastrointestinal bleeding

                                               No.: 383 (%)   No.: 189 (%)
  -------------------------------------------- -------------- --------------
  Abnormal findings in esophagus               117(31)        53 (28)
   Varices[\#](#T000F5){ref-type="table-fn"}   47             17
   GERD^\$^                                    23             14
   Other esophagitides                         8              3
   Mai lory-Weiss--s tears ± ulcer             34             13
   Mass                                        5              6
  Abnormal findings in stomach                 150 (39)       58 (31)
   Ulcer                                       124            49
   Site of ulcer                                              
   Cardia                                      9              3
   Fundus                                      32             14
   Lesser curvature                            38             19
   Greater curvature                           22             3
   Antrum                                      11             2
   Pre-pyloric area and pylorus                12             8
   Description of ulcer/s                                     
   Clean based                                 41             22
   With simple clot                            19             5
   With oozing of blood from ulcer bed         34             15
   With adherent clot                          13             3
   With visible vessel                         13             2
   With spurting artery                        4              0
   Gastritis                                   16             2
   Mass                                        6              4
   Vascular ectasia                            4              3
  Abnormal findings in duodenum                63(16)         32 (17)
   Ulcer                                       62             31
   Description of ulcer/s                                     
   Clean based                                 34             14
   With simple clot                            4              5
   With oozing of Wood from ulcer bed          12             7
   With adherent clot                          4              3
   With visible vessel                         4              3
   With spurting artery                        4              1
   Vascular ectasia                            1              0
   Mass                                        0              1
  Normal                                       53 (14)        46 (24)

13/64 of these patients had concomitant gastric and/or duodenal ulcer

Injection therapy and/or argon plasma coagulation was done for 54 patients with high risk ulcers and 12 (22%) of them had high risk ulcers in second look endoscopy. Blood transfusion was required in 197 patients and finally, mortality rate of our patients was 6% for *de novo* and 7% for in-hospital patients respectively \[[Table 4](#T0004){ref-type="table"}\].

###### 

End points in *de novo* and in-hospital patients with upper gastrointestinal bleeding

                                                Whole No.: 572   *de novo* No.: 383   In hospital No.: 189
  --------------------------------------------- ---------------- -------------------- ----------------------
  Injection therapy ± APC of ulcer              54               42                   12
  Sclerotherapy of esophageal varices           53               40                   13
  Rubber band ligation                          11               7                    4
  Blood transfusion                             197              98                   99
  Re-endoscopy                                  76               39                   37
  High risk ulcers in re-endoscopy              12               10                   2
  Mean hospital staying /day (±SD)              3.7 (4.4)        2.4 (2.2)            6.3 (6.3)
  Death in hospital due to acute UGI bleeding   36 (6%)          22 (6%)              14 (7%)

The mortality rate was higher in older patients, patients with orthostatic hypotension on arrival and patients who consumed steroids \[[Table 5](#T0005){ref-type="table"}\].

###### 

Comparison between alive and deceased patients with upper gastrointestinal bleeding

                                               Whole No.: 572 (%)   Alive No.: 536 (%)   Deceased No.: 36 (%)                        *P* value (Alive *vs*. deceased)
  -------------------------------------------- -------------------- -------------------- ------------------------------------------- --------------------------------------
  Sex                                                                                                                                
   Male                                        377 (66)             351 (65)             26 (72)                                     NS[\#](#T000F6){ref-type="table-fn"}
   Female                                      195 (34)             185 (35)             10(28)                                      
  Mean age/ yr (±SD)                           54-9(18.7)           54.2 (18.7)          64.8(16.3)                                  0.001
  History related to bleeding                                                                                                        
   Melena                                      217 (38)             200 (38)             17(47)                                      NS
   Hematemesis or coffee-ground vomitus        390 (68)             367 (69)             23(64)                                      NS
   Fainting or dizziness                       77(14)               72 (13)              5(14)                                       NS
   Hematochezia                                22(4)                22(4)                0                                           NS
  Previous history of                                                                                                                
   Duodenal ulcer                              24(4)                23 (4)               1(3)                                        NS
   Gastric ulcer                               67(12)               59(11)               8(22)                                       0.04
   Portal hypertension                         12(2)                12(2)                0(0)                                        NS
   Cirrhosis                                   38 (7)               36 (7)               2(6)                                        NS
   Gl bleeding                                 66(12)               61 (11)              5(14)                                       NS
   Peptic ulcer                                6                    6                    0                                           NS
   Varices                                     49                   44                   5                                           NS
  Co-morbidities                               400 (70)             370 (69)             30 (83)                                     NS
   Ischemic heart disease                      34                   32                   2                                           NS
   Renal failure                               9                    8                    1                                           NS
   Cerebro-vascular accident                   37                   36                   1                                           NS
   Malignancies                                37                   35                   2                                           NS
   Hypertension                                87                   80                   7                                           NS
   Trauma                                      22                   19                   3                                           NS
   Others                                      174                  160                  14                                          NS
  History of drug consumption:                                                                                                       
   ASA                                         172 (30)             161 (30)             11 (31)                                     NS
   Celecoxib                                   10(2)                10(2)                0                                           NS
   Other NSAIDs                                255 (45)             239 (45)             16(44)                                      NS
   Steroids                                    53 (9)               43 (8)               10 (28)[\$](#T000F7){ref-type="table-fn"}   0.001
   Warfarin                                    42 (7)               39 (7)               3(8)                                        NS
  Mean second hemoglobin(gnVdl)                10.9                 10.9                 10.8                                        NS
  Orthostatic hypotension on arrival           291 (51)             267 (50)             24 (67)                                     0.018
  Abnormal prothrombin time                    101 (18)             94 (18)              7(19)                                       NS
  Partial thromboplastin time                  104(18)              96 (18)              8(23)                                       NS
  Endoscopic findings                                                                                                                
   Esophageal varices                          64(11)               59(11)               5(14)                                       NS
   GERD                                        37(6)                35 (7)               2(6)                                        NS
   Esophageal ulcer                            47 (8)               44(8)                3(8)                                        NS
   Esophageal mass                             11(2)                10(2)                1(3)                                        NS
   Gastric ulcer                               173 (30)             163 (30)             10(28)                                      NS
   Gastritis                                   18(3)                14(3)                4(11)                                       0.02
   Mass                                        10(2)                8(1)                 2(6)                                        NS
   Duodenal ulcer                              93(16)               89 (17)              4(11)                                       NS
  Hospital staying/day in *de novo* patients   2.4                  2.4                  3.3                                         0.045

NS means statistically not significant

7/10 of these patients consumed aspirin or other NSAIDs concomitantly

Analysis showed that mortality was directly related to increase in age \[[Table 6](#T0006){ref-type="table"}\].

###### 

The mortality rate and age of patients with upper gastrointestinal bleeding

  Age group in years (mortality %)            Alive   Deceased
  ------------------------------------------- ------- ----------
  \<50 (4)                                    206     8
  50--59 (3)                                  97      3
  60--69 (6)                                  104     7
  70--79 (14)                                 80      13
  80--89 (9)                                  50      5
  ≥90 (0)                                     2       0
  ≤60 (4)[\#](#T000F8){ref-type="table-fn"}   300     11
  \>60 (10)                                   236     25

Mortality rate between ≤60 years old patients and higher than 60 years old patients were significant (*P* value: 0.003)

Comparison between ≤60 and \>60 years old patients showed that older patients had more serious presentations (hematemesis or coffee-ground vomits, orthostatic hypotension or shock on arrival). They consumed aspirin, alcohol, steroids, warfarin, smoked water-pipe and cigarettes more than younger patients and eventually, acid peptic disease as the cause of AUGIB was more frequent in older patients \[[Table 7](#T0007){ref-type="table"}\]. Thirty four patients who consumed steroids in this age group, also consumed aspirin or other NSAIDs and seven of these patients died. Acid peptic disease as the cause/s of AUGIB was more frequently found in older patients \[[Table 7](#T0007){ref-type="table"}\].

###### 

Comparison between younger (≤60 years) and older (\>60 years) patients with upper gastrointestinal bleeding

                                         ≤60 years No: 311 (%)   \>60 years No: 261 (%)                      *P* value
  -------------------------------------- ----------------------- ------------------------------------------- --------------------------------------
  Male/Female                            205/106                 172/89                                      NS[\#](#T000F9){ref-type="table-fn"}
  *de novo*/In hospital                  207/104                 176/85                                      NS
  Melena                                 127 (41)                90 (34)                                     NS
  Hematemesis or coffee ground vomitus   200 (64)                190 (73)                                    0.019
  Co-morbidities                                                                                             
   Ischemic heart disease                14(5)                   20 (8)                                      
   Cerebrovascular accident              5(2)                    32(12)                                      
   Hypertension                          25 (8)                  62 (24)                                     
   Trauma                                17(5)                   5(2)                                        
  NSAID consumption                      191 (61)                246 (94)                                    0.0001
   ASA                                   44 (14)                 128 (49)                                    0.0001
   Celecoxib                             5(2)                    5(2)                                        NS
   Other NSAIDs                          142 (46)                113(43)                                     NS
  Steroid consumption                    13(4)                   40(15)[\$](#T000F10){ref-type="table-fn"}   0.0001
  Warfarin consumption                   11 (4)                  31 (12)                                     0.0001
  Alcohol consumption                    19(6)                   29 (11)                                     0.035
  Water pipe smoking                     49 (16)                 90 (34)                                     0.0001
  Cigarrette smoking                     92 (30)                 107 (41)                                    0.005
  Orthostatic hypotension on arrival     146 (48)                145 (57)                                    0.027
  Shock on arrival                       8(3)                    18(7)                                       0.015
  Major causes of bleeding                                                                                   
   Esophageal varices                    36 (12)                 28 (11)                                     NS
   GERD                                  25 (8)                  12(5)                                       NS
   Mallory-Weiss' tear/ulcer             22 (7)                  25(10)                                      NS
   Esophageal mass                       4(1)                    7(3)                                        NS
   Gastric ulcer                         86 (28)                 86 (33)                                     0.03
   Gastritis                             12(4)                   6(2)                                        NS
   Gastric mass                          6(2)                    4(2)                                        NS
   Duodenal ulcer                        44 (14)                 49(19)                                      0.04
   Gastric ulcer and/or duodenal ulcer   124 (40)                128 (49)                                    0.028

NS: Statistically not significant

34/40 of these patients consumed aspirin (13 patients) or other NSAIDs (23 patients) concomitantly and 7/10 of patients who concomitantly consumed aspirin (2/10) or other NSAIDs (5/10) and steroids deceased

DISCUSSION {#sec1-3}
==========

Because of shortcomings in records, this study was done prospectively with predefined strategy and goals in the two largest referral centers in southern Iran i.e., Faghihi and Namazi Hospitals.

Only patients who were admitted in hospital for a minimum of 8 hours were considered for the study and followed up to the end point, so automatically patients with minor bleeding were excluded. As a result, in our study the most common presentation of AUGIB was hematemesis or vomiting of coffee-ground material in both *de novo* and in-hospital patients \[[Table 1](#T0001){ref-type="table"}\]; orthostatic hypotension was seen in 291 (51%) of patients, the most common cause of AUGIB was acid peptic disease and not gastritis (such as study of Boonpongmanee S. *et al*\[[@CIT5]\]), and only 63/173 (36%) of gastric ulcers and 46/93 (49%) of duodenal ulcers were clean-based.

As a developing country, statistical analysis of demographic data in this survey showed that there is no difference between our results in sex (66% male) and mean age (54.9 year old) in comparison with the same studies in developed countries.\[[@CIT2][@CIT4]\]

Due to progressive and drastic changes in medical and health care systems, the age and life expectancy of general population has been increasing in Iran, and in this way some of the common geriatric problems such as coronary artery disease, degenerative joint disease and osteoarthropathies and eventually excessive consumption of all kinds of NSAIDs and low dose aspirin as main standard therapies has increased. It seems that this expansive usage of these drugs led to increasing rate of GU as a cause of AUGIB and this may be comparable with results of Enestvedt *et al*.\[[@CIT1]\] On the other hand, according to the above facts and considering the effective newer and widespread management of *H. pylori* as a major cause of peptic ulcer and gastric cancer, introducing gastric ulcer as a new leading cause of AUGIB is confirmed by our study (GU 30%, DU 16%).\[[@CIT10][@CIT12]\] Meanwhile, the decreasing rate of variceal bleeding (11%) may be explained by the extensive usage of effective drugs for chronic hepatitis/cirrhosis caused by hepatitis B and C viruses and autoimmune hepatitis, in addition to a vast usage of propanolol and rubber band ligation as primary prevention methods for variceal bleeding.

Comparing similar studies,\[[@CIT13]\] the reduction in hospital stay, from a standard 5.5 days to 2.2 days, can be explained by better management of AUGIB.

Mortality rate of AUGIB in our centers was comparable to centers in developed countries.\[[@CIT11]\] We compared some of the data between alive and deceased patients.

The first finding was mean age (54 vs. 65 years, *P* = 0.001). Mortality rate was significantly different for. 60 years (4%) versus \>60 years (10%, *P* = 0.003). Further analysis showed that this finding may be secondary to more blood loss before referral \[[Table 7](#T0007){ref-type="table"}\] and frequent consumption of aspirin or other anticoagulants.\[[@CIT3][@CIT14]\] Further, this is also secondary to concomitant diseases such as ischemic heart disease and cerebro-vascular accident, which have a higher frequency in older patients. Acid peptic disease as the major cause of AUGIB was more frequent in older patients (40% in younger vs 49% in older patients respectively, *P* = 0.028). The second finding in deceased patients was past history of steroids usage which also was statistically different (8% in alive Vs 28% in deceased patients respectively, *P* = 0.001). External steroids, by themselves, are not harmful for stomach or duodenum but concomitant use of steroids and NSAIDs usually increase the risk of gastric and duodenal ulceration and AUGIB.\[[@CIT15]\] Our study showed (just like Shorr *et al* findings)\[[@CIT16]\] that concomitant use of steroids and NSAIDs may also increase the mortality secondary to AUGIB in this subset of patients. 45 out of 53 (85%) steroids users concomitantly used NSAIDs, while 7 out of 10 died due to AUGIB.

Acute (15-day) mortality rate in patients with esophageal variceal bleeding (5/64, 8%) was comparable with other nonvariceal causes such as acid peptic disease (13/252, 5%) and this may be secondary to better management of these patients and/or use of newer therapeutic modalities to stop the bleeding in this group. This result agrees with findings of Chalasani N *et al*.\[[@CIT9]\]

In conclusion, it appears that the most common cause of AUGIB is acid peptic disease, which increases with the age of the patient, and frequent consumption of NSAIDs, and gastric ulcer as the main source of bleeding may be NSAIDs induced. It is therefore suggested to take a thorough history pertaining to acid peptic disease, before the start of aspirin, and decrease the threshold of performing upper gastrointestinal endoscopy and possibly prescription of proton pump inhibitors especially in high risk groups (older age, concurrent anticoagulant, or steroid users, etc). Furthermore eradication of *H. pylori* prior to starting aspirin or other NSAIDs may decrease the rate of AUGIB secondary to acid peptic disease.\[[@CIT11]\] Finally, in this regard, consideration of international recommendations on starting aspirin or other NSAIDs will be helpful.
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